Annual Newsletter 2017

Download a copy here. Newsletter_Autumn_2017.pdf

Latest

The Behaviours of Alpha-Synuclein

Researchers are beginning to better understand the behaviours of the alpha-synuclein protein implicated in Parkinson's. In this article, Linked Clinical Trials committee member David Sulzer discusses the findings...
Could Changes in the Levels of Serotonin Signal Parkinson's?

Researchers from King's College London have uncovered the earliest signs of Parkinson's in the brain, long before any symptoms are evident. The results could potentially lead to screening tools for identifying people at greatest risk - an important area of research interest...
CuATSM - A Promising Compound

Following on from interesting results in a clinical trial of motor neurone disease earlier this year this new study in Parkinson's further supports the potential utility of this compound...
The Ridgway Mini-Fest

Join supporter and long time friend of The Cure Parkinson’s Trust Barbara Thompson for a fantastic afternoon of music and food at The Ridgway Mini-Fest on Saturday 27th July.

The Behaviours of Alpha-Synuclein

Researchers are beginning to better understand the behaviours of the alpha-synuclein protein implicated in Parkinson's. In this article, Linked Clinical Trials committee member David Sulzer discusses the findings...
Could Changes in the Levels of Serotonin Signal Parkinson's?

Researchers from King's College London have uncovered the earliest signs of Parkinson's in the brain, long before any symptoms are evident. The results could potentially lead to screening tools for identifying people at greatest risk - an important area of research interest...
CuATSM - A Promising Compound

Following on from interesting results in a clinical trial of motor neurone disease earlier this year this new study in Parkinson's further supports the potential utility of this compound...
Anle-138b - New Research Suggests Neuroprotection

Recently published new research by UK scientists - supported by The Cure Parkinson's Trust - suggest a new treatment that breaks down toxic protein aggregates could be neuroprotective in Parkinson's...
Webinar - Stem Cell (Cell Replacement) Therapy

Our recent webinar (June 2019) discusses developments in the field of stem cell therapy for Parkinson's. Watch now...
The Mike Tindall Celebrity Golf Classic 2019

Celebrity guests joined Mike Tindall MBE and his wife, Zara, for the Celebrity Golf Classic held at The Belfry with funds raised going to CPT's research...
The AEGIS Coast to Coast to Cure Challenge

13 supporters of The Cure Parkinson’s Trust (CPT), including CPT Patron Mike Tindall MBE and fellow Rugby World Cup winner Iain Balshaw MBE, completed the historic 'Raid Pyrenean', this week to raise vital funds for CPT’s search for a cure for Parkinson’s.
The 'Coast To Coast To Cure' Endurance Cycle

This week AEGIS London and The Cure Parkinson’s Trust (CPT) hosted a Q&A event with rugby legends Mike Tindall and Iain Balshaw to talk about Parkinson’s, CPT’s ground-breaking research and the extreme Coast to Coast to Cure Challenge...
World Parkinson Congress, Kyoto: 4-7 June 2019

This triennial congress provides an international forum for dialogue on the latest scientific discoveries, medical practices, and caregiver initiatives related to Parkinson’s disease...
Early Indication from Study Shows Dietary Supplement may Improve Dopamine Function and Ease Motor and Non-Motor Symptoms of Parkinson's

Investigators at Thomas Jefferson University, Philadelphia have reported that in a study of 42 patients, those who received N-acetyl cyteine (NAC) experienced a significant lessening of the motor and non-motor symptoms. The results suggest that NAC may positively affect the dopaminergic system in people with Parkinson's, with corresponding positive clinical effects.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more

Parkinson's Movement

The Science of Parkinson's - Dr Simon Stott

Leave a gift in your Will

A donation to The Cure Parkinson's Trust will make a huge difference to our research to slow, stop or even reverse Parkinson's. Read more